American Diabetes Association
Browse

Diabetes genetic clusters and clinical outcomes in American Indians

Download (4.11 MB)
figure
posted on 2025-08-18, 17:44 authored by Kaylia M. Reynolds, Quan Sun, Ying Zhang, Jason Umans, Shelley A. Cole, Andrew P. Morris, Nora Franceschini
<p dir="ltr">Diabetes has a large medical and public health impact in American Indians. Studies have used genetic data to distinguish type 1 (T1D) and type 2 diabetes (T2D) and uncover biologic mechanisms underlying T2D clinical heterogeneity. We applied a T1D polygenic score (PS) to 3,084 American Indians (mean age 56 years, 58% female, 39% diabetes). We also calculated partitioned PS for eight clusters of T2D-associated variants and evaluated their association with twenty cardiometabolic traits and five clinical outcomes. The profile of T1D PS for individuals with diabetes was consistent with T2D. A total T2D PS was significantly associated with early age of onset of T2D (p-value = 3.5x10<sup>-11</sup>). Partitioned PS for T2D clusters were significantly associated with cardiometabolic traits for the obesity cluster (increased measures of body fat and total triglycerides but lower HDL cholesterol), while the lipodystrophy cluster was associated with increased fasting insulin, waist/hip ratio, triglycerides, and blood pressure and lower body fat % and HDL cholesterol. T2D clusters were not associated with cardiovascular and kidney outcomes. Our findings support a relationship of cluster-specific T2D partitioned PS with cardiometabolic traits described in other populations but there are opportunities for developing improved clustering methods using genetic variation from American Indians.</p>

Funding

SHS has been funded in whole or in part with federal funds from the NHLBI, NIH, Department of Health and Human Services, under contract nos. 75N92019D00027, 75N92019D00028, 75N92019D00029, and 75N92019D00030. The study was previously supported by research grants: R01HL109315, R01HL109301, R01HL109284, R01HL109282, and R01HL109319 and by cooperative agreements U01HL41642, U01HL41652, U01HL41654, U01HL65520, and U01HL65521. The MEGA array was genotyped under the National Institute on Minority Health and Health Disparities, NIH R01MD012765 to NF. This study was also supported by the National Institute of Health grants R01DK117445 and R01HL163972 to NF. APM was supported by Versus Arthritis (21754) and the NIHR Manchester Biomedical Research Centre (NIHR203308).

History

Usage metrics

    Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC